Valeant Pharmaceuticals International (VRX) Fell On FDA News

Valeant Pharmaceuticals International (VRX) announced Monday that the U.S. FDA has failed to approve the Canadian company's Duobrii lotion for the treatment of plaque psoriasis.

from RTT - Before the Bell https://ift.tt/2lfYDOK
via IFTTT